XNCR - Xencor slides amid plans for early-stage trial data for kidney cancer drug
2025-10-14 13:29:54 ET
More on Xencor
- Xencor: Bispecific Antibody Program Takes Shape With Q4 Data Release
- Erasca, Candle, Xencor drop as BofA downgrades on lack of near-term catalysts
- Seeking Alpha’s Quant Rating on Xencor
- Historical earnings data for Xencor
- Financial information for Xencor